Decibel Cannabis Co. Adjusts Valuation Amid Rising Costs and Mixed Financial Metrics

Decibel Cannabis Co., Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in its valuation score, which has transitioned from attractive to fair.
Key financial metrics indicate that the company is navigating a complex landscape. The P/E ratio remains unavailable due to the company being loss-making, while the Price to Book Value stands at 1.20. The EV to EBIT and EV to EBITDA ratios are notably negative, at -9.31 and -18.39, respectively. Additionally, the Return on Capital Employed (ROCE) is reported at -12.18%, and the Return on Equity (ROE) is at -0.07%.

Despite these challenges, Decibel Cannabis Co., Inc. has demonstrated a significant return of 150.00% over the past year, with profits rising by 99.7%. However, the company has faced pressures such as a 28.3% increase in raw material costs year-over-year and a low operating cash flow of CAD 2.37 million.

Overall, the stock's performance has shown resilience, outperforming the S&P/TSX 60 over various time frames.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.